100
Participants
Start Date
June 30, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
CHF 5259
Comparison of CHF 5259 versus placebo over a treatment period. Allocation of 1 of the 2 possible treatments performed in sequence during a cross over design.
Placebo
Comparison of CHF 5259 versus placebo over a treatment period. Allocation of 1 of the 2 possible treatments performed in sequence during a cross over design.
Chiesi Clinical Trial Site 1017, Sevlievo
Chiesi Clinical Trial Site 1010, Sofia
Chiesi Clinical Trial Site 1011, Sofia
Chiesi Clinical Trial Site 1014, Sofia
Chiesi Clinical Trial Site 1015, Sofia
Chiesi Clinical Trial Site 1016, Sofia
Chiesi Clinical Trial Site 1012, Stara Zagora
Chiesi Clinical Trial Site 1013, Troyan Municipality
Chiesi Clinical Trial Site 2024, Berlin
Chiesi Clinical Trial Site 2028, Berlin
Chiesi Clinical Trial Site 2027, Hamburg
Chiesi Clinical Trial Site 2026, Leipzig
Chiesi Clinical Trial Site 2023, Magdeburg
Chiesi Clinical Trial Site 2021, Radebeul
Chiesi Clinical Trial Site 2022, Witten
Chiesi Clinical Trial Site 3039, Bydgoszcz
Chiesi Clinical Trial Site 3032, Katowice
Chiesi Clinical Trial Site 3035, Krakow
Chiesi Clinical Trial Site 3037, Lubin
Chiesi Clinical Trial Site 3031, Ostrowiec Świętokrzyski
Chiesi Clinical Trial Site 3033, Oświęcim
Chiesi Clinical Trial Site 3038, Rzeszów
Chiesi Clinical Trial Site 3034, Tarnów
Chiesi Clinical Trial Site 3030, Wroclaw
Chiesi Clinical Trial Site 3036, Zgierz
Chiesi Clinical Trial Site 4042, London
Chiesi Clinical Trial Site 4041, Manchester
Site 2020 - Pulmonary Research Institute at Hospital Grosshansdorf, Großhansdorf
Site 4040 - Royal Brompton and Harefield NHS Foundation Trust; South Kensington Campus, London
Chiesi Farmaceutici S.p.A.
INDUSTRY